Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.
Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat ...
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
Results on FLT3 inhibitor crenolanib in combination with chemotherapy to be presented in talk at ASCO 2022
Children’s Oncology Group study shows benefit for children and adolescents with high-risk HL treated with the combination
A multidisciplinary research team led by Song Yao, PhD, Professor of Oncology in the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center and Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s ...
This site is intended for healthcare professionals